Detailed quantification of right ventricular function in tetralogy of Fallot: a 3D echocardiography study Authors: Jop W Schneijdenberg, Robert R Zwaan, Yue Chen, Daniel J Bowen, Robert M Kauling, Gerard van Burken, Johan G Bosch, Annemien E van den Bosch Published: 2026 ABSTRACT AbstractAimsTetralogy of Fallot (ToF) is a congenital heart disease requiring surgical repair in early childhood. Affected patients cope with severe right ventricle (RV)–related morbidity during adulthood, which is mostly attributed to RV remodelling. Improved understanding of RV remodelling patterns is essential for advancements in clinical decision-making and treatment planning. Consequently, a method to enable detailed quantification of directional components of RV function was developed using 3D echocardiography (3DE).Methods and resultsFrom RV-focused 3DE studies of 50 ToF patients and 50 healthy controls, 3D dynamic RV meshes were obtained using commercially available software (TomTec 4D RV-Function). A software tool was developed in-house to decompose RV contraction in longitudinal (LT), radial, and anteroposterior (AP) motion directions. Their respective contributions to RV ejection fraction (EF) were calculated. The AP contraction component was identified as the main contributor in RV function deterioration, showing significant relative reduction in ToF patients compared with healthy controls [38% (31–42) vs. 40% (37–44), P = 0.004]. Conversely, the LT direction showed significant relative increase in ToF compared with healthy controls [28% (26–33) vs. 26% (23–31), P = 0.009].ConclusionOur custom software allowed for effective directional decomposition of RV EF, enabling detailed quantification of RV function in patients with ToF. RV function deterioration was primarily due to a decreased contribution of AP wall motion to RV EF, whereas LT contribution showed relative increase. These findings highlight the need for more detailed RV function assessment for improved understanding of RV remodelling. Introduction Tetralogy of Fallot (ToF) is the most prevalent cyanotic congenital heart disease (CHD), accounting for a significant proportion of complex CHD.1 ToF is characterized by conal rotation and malseptation, resulting in a combination of four cardiac features: a ventricular septal defect, an overriding aorta, right ventricle (RV) outflow tract obstruction, and concomitant RV hypertrophy.2 Surgical repair is typically required early in life to relieve the RV from pressure and volume overload, thereby improving survival and long-term cardiac function.3–6 Despite successful early surgical intervention, long-term complications are common in ToF patients. A particularly notable sequela is pulmonary regurgitation (PR), which often arises as an iatrogenic consequence of surgical relief of RV outflow tract (RVOT) obstruction.7 Chronic PR leads to sustained RV volume overload, eventually promoting adverse RV remodelling, which progresses to RV dilation and dysfunction.8 Left untreated, RV dysfunction significantly increases morbidity and mortality in this patient population.9 Pulmonary valve replacement (PVR) is the cornerstone intervention for preventing severe RV dysfunction in ToF patients.10 However, the optimal timing for intervention remains debated, as robust evidence for early PVR is still lacking.11 A more precise understanding of the pathophysiological mechanisms driving RV functional deterioration is essential for optimizing patient-specific timing of PVR and improving long-term outcomes.12,13 Echocardiography remains the first-line imaging modality for the diagnosis and longitudinal monitoring of CHD. However, accurate assessment of RV function is inherently challenging due to the complex geometry, retrosternal anatomical position, and regional heterogeneity in contractile mechanics of the RV.14 Consequently, traditional echocardiographic measures of the RV inflow region, such as RV fractional area change and tricuspid annular plane systolic excursion (TAPSE), may fail to capture multi-dimensional remodelling changes occurring over time.15,16 A promising solution may be found in the use of 3D echocardiography (3DE) for RV function assessment. 3DE provides the advantage of capturing the entire RV, allowing for a more comprehensive and accurate evaluation of RV function from a single data set.15 This technology facilitates the quantification of global and regional RV mechanics, overcoming the limitations of conventional 2D echocardiography and improving diagnostic and prognostic accuracy.16–18 Emerging research suggests that RV remodelling in ToF patients is not limited to longitudinal functional decline but also involves complex non-longitudinal contractile adaptations. These changes include alterations in radial (RD) and anteroposterior (AP) contraction, which may serve as early indicators of RV deterioration and mechanical inefficiency.19,20 In addition, regional differences in contractile function have been described in patients with altered RV loading conditions, although these were only investigated in longitudinal (LT) direction.21 Identifying and quantifying multidirectional changes in RV contraction are crucial, as they may precede clinically detectable RV dysfunction.22 The aim of this study is to comprehensively assess and compare global and regional differences in RV function characteristics between ToF patients, relative to healthy controls. By leveraging advanced 3DE analyses, we aim to identify distinct patterns of RV remodelling in this CHD population, focusing on AP, RD, and LT contractile mechanics. Methods Study population An observational study of 50 ToF patients and 50 healthy controls was performed. Dynamic full volume RV-focused 3DE studies acquired between January 2014 and March 2023 in our specialist CHD centre were extracted from a research database (QoL,7 BioCon,23 Revive, and CLINIC-US study). An age-matched control group was composed of healthy volunteers who had undergone similar 3DE examination for research purposes (MRI-exercise24 and Navigator25 study). All transthoracic echocardiograms were reviewed by an experienced sonographer (D.B.), and 3DE imaging was performed if acquisition with good image quality was deemed feasible. This study was performed in accordance with the Declaration of Helsinki and study protocols were previously reviewed and approved by the local medical ethics committee (QoL: MEC2019-0465, BioCon: MEC2010-165; Revive: MEC2018-1541; CLINIC-US: MEC2025-0153; MRI-exercise: MEC2016-427; Navigator: MEC2013-447). Written informed consent was obtained from all study participants. Data acquisition 3DE acquisitions were taken from an apical window. Studies were performed during breath hold, using a Philips ultrasound system (EPIQ7, X5-1 matrix array transducer, Philips Healthcare, Best, The Netherlands). Recordings were either four- to six-beat full volume acquisitions or made with single-beat HeartModel software (Philips Healthcare, Best, The Netherlands). Frame rates ranged from 18 to 71 frames/s. Offline semi-automatic segmentation of 3DE data was performed using commercially available software (4D RV-Function 2.0, TomTec Imaging GmbH, Unterschleissheim, Germany). Contours were checked and manually adjusted by an experienced sonographer (D.B.). Output consisted of single beat 3D dynamic RV endocardial surface renderings. These 3DE-based 4D models of a ventricle are commonly referred to as ‘beutels’. Beutels were exported from TomTec as a set of triangulated mesh files, one per frame of the dynamic 3DE study. The number of files in a set varied per patient, depending on heart rate of the patient and frame rate of the acquisition. RV function analysis A software application for RV beutel analysis (RV-Dynamics) was developed and validated in-house in C++. For each patient, a complete set of RV triangulated mesh files was imported into the application for analysis. Detailed quantification of RV function was achieved through the decomposition of RV contraction into three orthogonal anatomical directions. RV wall motion was decomposed in AP, RD, and LT direction. This decomposition approach is in line with literature findings about anatomical myocardial muscle layer architecture and earlier studies on the quantification of RV contraction patterns.21,26,27 To ensure consistent axis definition for all patients, standardized orientation and alignment of all meshes was performed before analysis. A new co-ordinate system was defined with axes in AP, RD, and LT direction, corresponding to the x-, y-, and z-axis, respectively. First, a line was drawn between the centre points of the tricuspid and pulmonary valve. The LT-axis was defined from the apex to the midpoint of this line. Subsequently, the RD-axis was established perpendicular to the LT-axis and the line between both valves. Lastly, the AP-axis was defined perpendicular to the LT- and RD-axis. The origin of the co-ordinate system was located on the RV centre of mass in the end-systolic frame (Figure 1). Beutel orientation and axis definition. Septal view of the RV showing standardized anteroposterior (AP), radial (RD), and longitudinal (LT) axes originating from the RV centre of mass in the end-systolic frame. Accordingly, wall motion of beutels was decomposed into AP, RD, and LT direction. For the computation of decomposed wall motion components, either the x-, y-, or z-co-ordinate of all defined points was allowed to alter throughout the cardiac cycle, whilst keeping the other two co-ordinates constant on their end-diastolic value (see Supplementary data online, S1.2 Mesh decomposition). Hereby, specifically the movement in the direction of the deviating co-ordinate can be studied. As a result, three sets of decomposed meshes were created, representing wall motion in either AP, RD, or LT direction (Figure 2). Beutel decomposition. Decomposed beutels depicted as end-diastolic meshes (black) and end-systolic volumes (blue), showing total wall motion and decomposed wall motion in anteroposterior, radial, and longitudinal direction. From these decomposed beutels, decomposed ejection fraction (dEF) was calculated in AP, RD, and LT direction as a measure of directional RV function. EF is defined as the ratio between stroke volume and end-diastolic volume (EDV). Stroke volume is calculated by subtraction of end-systolic volume (ESV) from EDV [Formula (1)]. By using the ESV of decomposed beutels (ESVd) for stroke volume calculation, dEF resulting from wall motion in one specific anatomical direction was quantified [Formula (2)]. Hereby, dEF represents a volume-based measure of RV function. To study ratios between the three dEF components, relative dEF was determined by dividing one of the dEF values by the sum of all three dEF values [Formula (3)]. As a result, changes in contribution of each dEF component to global EF could be studied, independent of global RV function. More details about the software development and validation can be found in Supplementary data online. Regional RV function analysis For regional assessment of dEF and relative dEF, four RV regions were defined based on literature findings and expert opinion.28,29 This subdivision aimed to enable detailed assessment of regional RV function, and to quantify regional differences. Regions comprised the anterior free wall (AFW), inferior free wall (IFW), lateral free wall (LFW), and septum (Figure 3). Each defined point of the mesh was assigned to one of these regions, forming a regional surface. Regional dEF and regional relative dEF were computed by calculating partial EDV and ESV spanned between the regional surface and end-systolic centre of mass, using Formulas (2) and (3). Regional function of the septum was not included in analysis, as dEF did not prove meaningful in that region. Regional division of points on the RV surface. AFW, anterior free wall; IFW, inferior free wall; LFW, lateral free wall. Relation between RV and LV function The correlation of dEF and relative dEF with echocardiography derived left ventricular ejection fraction (LVEF) was investigated in the ToF population to assess functional interdependence between the RV and LV.30 Statistical analysis Data distributions were examined through histograms and the Shapiro–Wilk normality test, based on which further statistical methods were determined. Normally distributed, continuous variables were presented as mean ± SD and compared using Student’s t-test. Non-parametric variables were expressed as median and inter-quartile range (IQR) and compared using a Mann–Whitney U test. Pearson’s and Spearman’s coefficients were calculated for correlation assessment of parameters with normal and non-parametric distributions, respectively. RV function parameters were treated as non-parametric to facilitate interregional comparisons. A P-value below 0.05 was considered significant. Statistical analysis was performed in SPSS for Windows (Version 28.0, SPSS Inc., Chicago, IL, USA). Study parameters were compared between ToF patients and healthy controls. Results Baseline characteristics Baseline characteristics are shown in Table 1. ToF patients had a median age of 1.2 (0.6–4.9) years at surgical repair and 25 patients (50%) were treated with a transannular patch. At the time of this study, patients were at a median of 35 (21–43) years after surgical repair. RV end-diastolic volume indexed to body surface area was significantly higher in ToF patients compared with healthy controls [95 mL/m2 (77–120) vs. 61 mL/m2 (50–70), P < 0.001] and 21 ToF patients (42%) had moderate to severe PR. Additionally, ToF patients compared with healthy controls showed significant reduction in right ventricular ejection fraction (RVEF) [44% (40–50) vs. 58% (55–61), P < 0.001] and LVEF [54% (50–58) vs. 60% (57–65), P < 0.001]. Table 1Baseline characteristicsVariableToF(n = 50)Controls(n = 50) P-valueAge, years38 (22–46)34 (25–47)0.717Female, n (%)18 (36)16 (32)0.833BMI, kg/m224 (22–25)23 (22–25)0.904BSA, m21.9 ± 0.21.9 ± 0.20.274Surgical interventions Age at repair, years1.2 (0.6–4.9) Time since repair, years35 (21–43) Transannular patch, n (%)25 (50) Pulmonary valve replacement, n (%)27 (54)Rhythm Sinus rhythm, n (%)47 (94) Paced rhythm, n (%)3 (6)RV volume overload, n (%)24 (48) Moderate to severe PR, n (%)21 (42) Moderate to severe TR, n (%)3 (6)RV pressure overload, n (%)1 (2) Severe PS, n (%)1 (2)Echocardiography LVEF, %54 (50–58)60 (57–65)<0.001 RVEF, %44 (40–50)58 (55–61)<0.001 RV EDVi, mL/m295 (77–120)61 (50–70)<0.001 TAPSE, mm17 ± 426 ± 4<0.001 S’, cm/s11 ± 212 ± 2<0.001 FAC, %34 ± 843 ± 6<0.001Values are presented as mean ± SD, median (inter-quartile range), or number (percentage). BMI, body mass index; BSA, body surface area; FAC, fractional area change; LVEF, left ventricular ejection fraction; PR, pulmonary regurgitation; PS, pulmonary stenosis; RV EDVi, right ventricular end-diastolic volume indexed to BSA; RVEF, right ventricular ejection fraction; S′, peak lateral tricuspid annular systolic velocity; TAPSE, tricuspid annular plane systolic excursion; ToF, tetralogy of Fallot; TR, tricuspid regurgitation. Baseline characteristics Values are presented as mean ± SD, median (inter-quartile range), or number (percentage). BMI, body mass index; BSA, body surface area; FAC, fractional area change; LVEF, left ventricular ejection fraction; PR, pulmonary regurgitation; PS, pulmonary stenosis; RV EDVi, right ventricular end-diastolic volume indexed to BSA; RVEF, right ventricular ejection fraction; S′, peak lateral tricuspid annular systolic velocity; TAPSE, tricuspid annular plane systolic excursion; ToF, tetralogy of Fallot; TR, tricuspid regurgitation. RV function in ToF dEF was found to be significantly reduced over all decomposition directions in ToF patients compared with healthy controls (P < 0.001). Largest reduction in dEF was observed in the AP direction, followed by the RD and LT direction, respectively (Table 2). Thereby, the AP contraction component was identified as the main factor in the deterioration of RV function. Table 2Decomposed and relative decomposed RV ejection fraction in ToF and healthy controlsDecomposed EFRelative decomposed EFDirectionToF(n = 50)Controls(n = 50) P-valueToF(n = 50)Controls(n = 50) P-valueAnteroposterior21 (17–24)31 (26–35)<0.00138 (31–42)40 (37–44)0.004Radial19 (15–23)24 (22–30)<0.00133 (29–39)32 (29–38)0.649Longitudinal16 (14–18)20 (17–24)<0.00128 (26–33)26 (23–31)0.009Values are presented as percentages, median (inter-quartile range). EF, ejection fraction; ToF, tetralogy of Fallot. Decomposed and relative decomposed RV ejection fraction in ToF and healthy controls Values are presented as percentages, median (inter-quartile range). EF, ejection fraction; ToF, tetralogy of Fallot. Relative dEF in AP direction was slightly, but significantly (P = 0.004) reduced in ToF patients [38% (31–42)] compared with healthy controls [40% (37–44)]. In contrast, a significant increase (P = 0.009) of relative dEF in longitudinal direction was observed in ToF patients [28% (26–33)] compared with healthy controls [26% (23–31)]. The RD component of relative dEF showed no significant difference between both groups (Table 2, Figure 4). Comparison of relative decomposed RV ejection fraction between ToF patients and healthy controls. ToF, tetralogy of Fallot. Regional RV function in ToF Regional assessment of dEF identified the IFW as the region with the highest regional EF in ToF patients, followed by the LFW and AFW, respectively. In healthy controls, the LFW exhibited the highest regional EF, followed by the IFW and AFW (Table 3). Comparing ToF patients to healthy controls, dEF was significantly reduced in all regions, except for the LT component in the AFW. Table 3Regional decomposed and regional relative decomposed RV ejection fraction in ToF and healthy controlsDecomposed EFRelative decomposed EFRegionDirectionToF(n = 50)Controls(n = 50) P-valueToF(n = 50)Controls(n = 50) P-valueAFWTotal37 (32–45)50 (46–55)<0.001Anteroposterior20 (14–24)31 (24–37)<0.00136 (28–44)44 (37–53)<0.001Radial16 (11–20)21 (16–25)0.00633 (23–37)31 (23–35)0.356Longitudinal16 (15–19)18 (14–21)0.27332 (28–37)26 (22–30)<0.001LFWTotal46 (42–52)65 (62–68)<0.001Anteroposterior21 (17–25)32 (28–37)<0.00138 (35–42)39 (36–46)0.101Radial19 (15–22)26 (21–32)<0.00134 (28–38)33 (27–40)0.852Longitudinal16 (14–19)21 (18–25)<0.00129 (25–33)26 (23–31)0.086IFWTotal52 (47–57)64 (62–66)<0.001Anteroposterior21 (17–25)28 (25–32)<0.00135 (32–43)39 (35–44)0.046Radial20 (16–24)23 (19–28)0.00333 (28–37)31 (28–38)0.210Longitudinal17 (15–20)21 (19–25)<0.00128 (27–34)30 (24–34)0.482Values are presented as percentages, median (inter-quartile range). AFW, anterior free wall; EF, ejection fraction; IFW, inferior free wall; LFW, lateral free wall; ToF, tetralogy of Fallot. Regional decomposed and regional relative decomposed RV ejection fraction in ToF and healthy controls Values are presented as percentages, median (inter-quartile range). AFW, anterior free wall; EF, ejection fraction; IFW, inferior free wall; LFW, lateral free wall; ToF, tetralogy of Fallot. Within the AFW, a significant decrease (P < 0.001) of relative dEF in AP direction was observed in ToF patients [36% (28–44)] compared with healthy controls [44% (37–53)]. Conversely, relative dEF in LT direction was significantly increased (P < 0.001) in ToF patients [32% (28–37)] compared with healthy controls [26% (22–30)] (Table 3). With a decrease of dEF in AP direction and an increase in LT direction, the AFW demonstrated a regional dEF pattern comparable to the distribution of relative dEF found in the global RV (Table 2). Changes in relative dEF were less pronounced in other regions. Correlation between LVEF and RV function A significant Spearman’s correlation with an rs of 0.412 (0.143–0.625) was found between dEF in the RD direction and LVEF (P = 0.003). dEF in the LT direction also showed a significant Spearman’s correlation with an rs of 0.455 (0.194–0.656) with LVEF (P < 0.001). In contrast, the AP component of dEF did not show significant correlation with LVEF. In addition, relative dEF did not show significant correlation with LVEF in AP, RD, or LT direction (Table 4). Table 4Correlation between LV ejection fraction and decomposed and relative decomposed RV ejection fraction in patients with ToFDecomposed EFRelative decomposed EFDirectionCorrelation coefficient P-valueCorrelation coefficient P-valueAnteroposterior0.272 (−0.015–0.518)0.056−0.156 (−0.423–0.137)0.281Radial0.412 (0.143–0.625)0.0030.178 (−0.114–0.442)0.216Longitudinal0.455 (0.194–0.656)<0.0010.029 (−0.259–0.313)0.840Values are presented as Spearman’s coefficients (r­s) (95% confidence interval). EF, ejection fraction; ToF, tetralogy of Fallot. Correlation between LV ejection fraction and decomposed and relative decomposed RV ejection fraction in patients with ToF Values are presented as Spearman’s coefficients (r­s) (95% confidence interval). EF, ejection fraction; ToF, tetralogy of Fallot. Discussion A software application was developed for detailed quantification of global and regional RV function using 3DE. This application allowed for the objective assessment of dEF and relative dEF of the RV, demonstrating the ability to quantify RV remodelling in ToF patients by comparing them to healthy controls. Our findings revealed that the AP component of dEF was the largest contributor to RVEF and exhibited the greatest reduction in ToF patients compared with healthy controls. Unlike dEF in the RD and LT directions, the AP component did not correlate significantly with LVEF, indicating potential independence of left ventricular function. At a regional level, the IFW displayed the highest EF in ToF patients, suggesting that this region contributes most to overall RV function. Additionally, the AFW mirrored the remodelling patterns observed at the global RV level, as evidenced by similar dEF and relative dEF distributions. Thereby, this study demonstrated that RV remodelling is a heterogeneous process across different regions, emphasizing the importance of regional RV function assessment in ToF patients. By leveraging advanced 3DE-derived metrics, our findings provide novel insights into RV adaptation mechanisms in CHD. To the authors’ knowledge, this is the largest study of its kind to comprehensively evaluate global and regional RV function using 3DE in ToF patients, further refining our understanding of RV mechanics and potential targets for clinical intervention. Global RV remodelling The investigation of RV contraction in various anatomical directions provided insights into the heterogeneity of functional RV remodelling. It was observed that EF derived from wall motion in the LT direction contributed the least to RVEF in both ToF patients and healthy controls. These findings challenge the effectiveness of widely used 2D echocardiographic parameters for RV functional assessment. Current guidelines recommend functional parameters, such as TAPSE (m-mode), peak lateral tricuspid annular systolic velocity (S′, tissue Doppler imaging), and longitudinal strain (speckle-tracking echocardiography), for RV function assessment. These parameters primarily quantify longitudinal RV contraction.15,16,31 However, our results indicate that dEF in LT direction shows the least deterioration in ToF patients compared with the RD and AP components of dEF. This suggests that longitudinal parameters alone may not sufficiently capture the extent of RV dysfunction in ToF patients. A novel approach utilizing 3D decomposition of EF could provide a more detailed assessment of functional remodelling, potentially identifying early-stage disease progression before clinically evident deterioration occurs. Our findings contrast with those of Bidviene et al., who reported that dEF in the LT direction was the largest contributor to RVEF, whereas dEF in the AP direction contributed the least in ToF patients.20,32 Notably, the population studied by Bidviene et al. was younger and predominantly female, with more severe RV dilatation and a high percentage of transannular patch repair. The discrepancies in AP and LT contributions to RVEF observed in our study may therefore reflect population-dependent variations in RV remodelling patterns, emphasizing the need for age- and sex-specific assessments of RV function at various stages of disease. In ToF patients, dEF in AP direction demonstrated the most pronounced decrease, whereas the LT component exhibited the least reduction in function compared with healthy controls. This led to an increase in relative dEF in LT direction, driven by a smaller reduction in LT function compared with other anatomical directions. This finding indicates that RV functional impairment in LT direction is present, although less pronounced than in other directions. Correlation analysis between dEF and LVEF revealed that the AP component did not significantly correlate with LVEF, unlike the RD and LT components. This suggests that functional reduction in the AP direction could represent a unique feature of RV remodelling in ToF, which may not be effectively captured by conventional LV-based assessment methods. As a result, the AP component of dEF may serve as a valuable indicator of advanced functional RV remodelling in ToF patients. However, further prospective validation of this finding is warranted to assess its independence of LV function and contribution to RV remodelling, before its potential for integration into risk stratification models for timely intervention and optimized patient management can be determined. Regional RV remodelling Regional analysis of dEF suggests that the AFW plays a crucial role in functional RV remodelling in ToF patients. The patterns observed in global relative dEF were mirrored in the AFW, with a significant decrease in relative dEF in the AP direction, a significant increase in the LT direction, and a preserved relative dEF in the RD direction. These findings suggest that the AFW may serve as a key region of interest for further research on functional remodelling of the RV in ToF patients. The AFW is anatomically located beneath the pulmonary valve and is part of the RVOT. Prior studies have documented notable anatomical alterations in this region in ToF patients, which may explain the observed remodelling patterns.33 Moreover, regional differences in RV function, particularly surrounding the RVOT, have been strongly linked to functional impairment in ToF patients, reinforcing the need for regional RV function assessment.23,34,35 A more targeted approach to RV functional analysis, focusing on regional contractile abnormalities, could help refine diagnostic and prognostic models in ToF patients, ultimately improving long-term clinical outcomes. Limitations Several limitations were inherent to the imaging technique used. High-quality ultrasound equipment and highly skilled sonographers are essential for successful 3DE acquisition. Only patients with feasibility of good quality 3DE were included. Consequently, investigated imaging techniques may not be fully applicable to all ToF patients, requiring further investigation. Additionally, imaging quality of the anterior RV wall may have been lower due to anatomical limitations, potentially affecting segmentation accuracy.36 Inter- and intra-observer variability were not investigated as part of this study. The developed software is fully deterministic and potential variability is solely caused by 3DE imaging. Inter- and intra-observer variability of 3DE-based EF have been extensively reported in literature, showing good repeatability,37,38 although some variation is introduced by manual adjustment of the segmentations. Similar variability is to be expected for the parameters used in this study as derivatives of EF were used. Validation data of the cohort were not available for this study, and the single-centre cross-sectional design limited the assessment of prognostic value. Therefore, future validation studies are required to determine the predictive value of the proposed parameters, and to evaluate their accuracy and reproducibility against established clinical measures. Future research With the ability to automatically quantify RV function from dynamic 3D RV meshes, further research is needed to gain more insight into RV remodelling processes. Our data set was not suited for long-term follow-up, but longitudinal studies in ToF patients could help identify regions undergoing significant remodelling over time. Prior research has demonstrated the prognostic value of regional RV deformation analysis in pulmonary hypertension, supporting its potential in ToF.28 A larger longitudinal ToF cohort is needed to establish remodelling biomarkers for clinical deterioration. Key parameters identified in this study include the AP component of dEF, with a focus on the AFW region. These biomarkers could aid in optimizing PVR timing, balancing the limited durability of artificial valves with the need to prevent irreversible RV dysfunction. However, as this is a single-centre cohort study, prospective studies are needed to externally validate and investigate the prognostic value of these parameters before they can be applied in clinical decision-making, for example, for the optimization of PVR timing. In addition, investigating differences between RV remodelling in volume and pressure overloaded RV would be of great value. Due to the large proportion of volume overloaded RV in this explorative study, distinction between remodelling in pressure and volume overloaded RV could not be established. Beyond ToF, studying other patient populations could provide valuable insights into disease-specific RV remodelling. Using the developed software application, dEF and relative dEF can be automatically derived from RV mesh files, enabling future research into functional RV remodelling across various cardiac conditions. Conclusions This study advances the understanding of RV remodelling in ToF patients by quantifying global and regional functional characteristics using 3DE imaging. A custom software application was developed for objective assessment, calculating dEF and relative dEF. Functional impairment of the RV was primarily due to a decreased AP wall motion contribution to RVEF, with AP dEF potentially representing a distinct RV remodelling effect. The AFW region mirrored global RV remodelling patterns, highlighting its importance for future research. The developed software enables automatic RV function quantification, facilitating RV remodelling research across different populations. Future longitudinal studies in ToF patients should evaluate remodelling progression and identify biomarkers for clinical deterioration. Supplementary Material